Knowledge Management System of Hefei Institute of Physical Science,CAS
Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply | |
Yu, Yang1; Zong, Xiangyun2 | |
2022-04-14 | |
发表期刊 | JAMA ONCOLOGY |
ISSN | 2374-2437 |
通讯作者 | Zong, Xiangyun(tigerzong@msn.com) |
DOI | 10.1001/jamaoncol.2022.0491 |
收录类别 | SCI |
语种 | 英语 |
WOS研究方向 | Oncology |
WOS类目 | Oncology |
WOS记录号 | WOS:000782627500007 |
出版者 | AMER MEDICAL ASSOC |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.hfcas.ac.cn:8080/handle/334002/128552 |
专题 | 中国科学院合肥物质科学研究院 |
通讯作者 | Zong, Xiangyun |
作者单位 | 1.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China 2.Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 6, Dept Breast Surg, 600 Yishan Rd, Shanghai 200233, Peoples R China |
推荐引用方式 GB/T 7714 | Yu, Yang,Zong, Xiangyun. Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply[J]. JAMA ONCOLOGY,2022. |
APA | Yu, Yang,&Zong, Xiangyun.(2022).Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply.JAMA ONCOLOGY. |
MLA | Yu, Yang,et al."Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial Reply".JAMA ONCOLOGY (2022). |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[Yu, Yang]的文章 |
[Zong, Xiangyun]的文章 |
百度学术 |
百度学术中相似的文章 |
[Yu, Yang]的文章 |
[Zong, Xiangyun]的文章 |
必应学术 |
必应学术中相似的文章 |
[Yu, Yang]的文章 |
[Zong, Xiangyun]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论